Clinical Trial Update: Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for SHR0302 tablets as monotherapy in active rheumatoid arthritis (RA) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SHR0302 tablets (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED